BioSpace News Archive

Drug Development

Four Biopharma Companies Aim for Big Milestones in 2022

Biopharma companies are building momentum to carry them through the bulk of 2022. BioSpace takes a look at some of the recent announcements.

January 7, 2022
·
3 min read
·
Alex Keown
Biotech Bay

AN2 Therapeutics Nets $80 million for Novel Lung Disease Program

California-based AN2 Therapeutics secured $80 million in a Series B funding round to help advance its novel nontuberculous mycobacterial lung disease program.

January 7, 2022
·
2 min read
·
Alvin Clavines
Genetown

Oxurion Provides Update on Clinical Pipeline Progress

Oxurion NV announced updates on its two clinical programs, THR-687, initially being developed for first line treatment of DME, and THR-149 being developed for second line treatment of DME.

January 7, 2022
·
8 min read
Genetown

Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines

Sanofi and Exscientia announced a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology, leveraging Exscientia’s end-to-end AI-driven platform utilizing actual patient samples.

January 7, 2022
·
8 min read
argenx Highlights Strategic Priorities for 2022

argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced its strategic priorities for 2022 and highlighted recent achievements from its broad immunology pipeline.

January 7, 2022
·
9 min read
Strong Cresemba® (isavuconazole) sales by Astellas in the U.S. trigger CHF 15 million sales milestone payment to Basilea

Basilea Pharmaceutica Ltd. announced that sales of the antifungal Cresemba® by its partner Astellas Pharma Inc. in the United States exceeded the threshold triggering a milestone payment to Basilea of CHF 15 million.

January 7, 2022
·
3 min read
Tooth Regeneration Market: High Incidence of Dental Issues to Drive the Market

Tooth regeneration is a stem cell-based regenerative medical procedure that is used in tissue engineering and stem cell biology sectors.

January 7, 2022
·
5 min read
Subperiosteal Implants Market: Growing Geriatric Population and High Prevalence Rate of Edentulism Globally is Boosting the Market

Dental implants are metal posts or frames that are surgically placed into the jawbone underneath the gums. These implants enable the doctor to mount and hold the substitute teeth on this framework.

January 7, 2022
·
5 min read
Plague Therapeutics Market: The live attenuated vaccine segment is likely to grow at a rapid pace during the forecast period

Plague is caused by Yersinia pestis, a zoonotic microorganism generally found in mammals and fleas. Individuals contaminated with Yersinia pestis frequently show symptoms after an incubation time of one to seven days.

January 7, 2022
·
4 min read
Pharyngitis Treatment Market: High prevalence and growing incidence of flu worldwide to drive the market

Pharyngitis is the medical condition that causes inflammation at the back of the throat which is known as pharynx.

January 7, 2022
·
5 min read